In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 9, 2001, Pages 2486-2494

  Kraiczy, P ^a   Weigand, J ^a   Wichelhaus, T A ^a   Heisig, P ^a   Backes, H ^a   Schafer V ^a   Acker, G ^a   Brade, V ^a   Hunfeld, K P ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; FLEROXACIN; GATIFLOXACIN; GEMIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SITAFLOXACIN; SPARFLOXACIN; TROVAFLOXACIN;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BORRELIA; BORRELIA BISSETTII; BORRELIA BURGDORFERI; BORRELIA VALAISIANA; COLORIMETRY; CONCENTRATION RESPONSE; CULTURE MEDIUM; DILUTION; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; ELECTRON MICROSCOPY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TICK; TIME;

ANTI-INFECTIVE AGENTS; BORRELIA BURGDORFERI GROUP; CEFTRIAXONE; CEPHALOSPORINS; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; NAPHTHYRIDINES; TIME FACTORS;

EID: 0034875636     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.9.2486-2494.2001     Document Type: Article

References (25)

1. Genomic fingerprinting of Borrelia burgdorferi sensu lato by pulsed-field gel electrophoresis
2. In vitro antimicrobial susceptibility testing of B. burgdorferi: Influence of test conditions on minimal inhibitory concentration (MIC) values
3. Molecular characterization of Borrelia burgdorferi sensu lato strains by pulsed-field gel electrophoresis
4. Lyme disease assay which detects killed Borrelia burgdorferi
5. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: A microdilution MIC method and time-kill studies
6. In vitro activity of vancomycin against the spirochete Borrelia burgdorferi
7. Review of the in vitro activity for gemifloxacin against Gram-positive and Gram-negative anaerobic pathogens
8. Roxithromycin in Lyme borreliosis: Discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans
9. New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances
10. Colorimetric in vitro susceptibility testing of penicillins, cephalosporines, macrolides, streptogramins, tetracyclines and aminoglycosides against Borrelia burgdorferi isolates
11. Isolation techniques for spirochetes and their sensitivity to antibiotics in vivo and in vitro
12. Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi
13. Natural synthesis of a DNA-binding protein from the C-terminal domain of DNA gyrase A in Borrelia burgdorferi
14. Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi isolates
15. Characteristics of the pathogen
16. Effect of an antibiotic combination on the propagation of Borrelia burgdorferi, causative agent of Lyme disease
17. The bactericidal activity of sparfloxacin
18. The place of quinolones in everyday clinical practice
19. Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones
20. Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato
21. Einteilung der fluorochinolone
22. In vitro and in vivo evaluation of LB203004, a new fluoronaphthyridone
23. Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis
24. 1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent